Mark Cranfield

1.4k total citations
19 papers, 1.1k citations indexed

About

Mark Cranfield is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Reproductive Medicine. According to data from OpenAlex, Mark Cranfield has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Public Health, Environmental and Occupational Health and 4 papers in Reproductive Medicine. Recurrent topics in Mark Cranfield's work include TGF-β signaling in diseases (8 papers), Reproductive Biology and Fertility (7 papers) and Ovarian function and disorders (4 papers). Mark Cranfield is often cited by papers focused on TGF-β signaling in diseases (8 papers), Reproductive Biology and Fertility (7 papers) and Ovarian function and disorders (4 papers). Mark Cranfield collaborates with scholars based in United Kingdom, Australia and New Zealand. Mark Cranfield's co-authors include Nigel P. Groome, Olli Ritvos, Sally L. Mellor, Gail P. Risbridger, N. L. Hudson, Karen L. Reader, Jennifer L. Juengel, Peter R. Smith, Kenneth P. McNatty and Anne R. O’Connell and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and Biology of Reproduction.

In The Last Decade

Mark Cranfield

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Cranfield United Kingdom 15 683 611 328 254 126 19 1.1k
M Antczak United States 10 527 0.8× 683 1.1× 454 1.4× 114 0.4× 68 0.5× 11 1.2k
Shoko Yamashita Japan 15 388 0.6× 822 1.3× 468 1.4× 216 0.9× 154 1.2× 45 1.1k
Zheng‐Bin Han China 11 288 0.4× 321 0.5× 170 0.5× 118 0.5× 64 0.5× 15 547
L.C. Giudice United States 10 356 0.5× 189 0.3× 411 1.3× 205 0.8× 76 0.6× 13 1.3k
Ilkka Ketola Finland 13 667 1.0× 313 0.5× 251 0.8× 471 1.9× 39 0.3× 13 1.0k
Noora Kaivo-Oja Finland 9 623 0.9× 679 1.1× 243 0.7× 107 0.4× 50 0.4× 12 854
Lihua Sun China 18 231 0.3× 341 0.6× 377 1.1× 49 0.2× 9 0.1× 43 802
Elissavet Hatzi Greece 16 356 0.5× 163 0.3× 231 0.7× 108 0.4× 9 0.1× 35 743
Chencheng Yao China 19 571 0.8× 411 0.7× 635 1.9× 334 1.3× 5 0.0× 64 1.1k
Patricia da Silva‐Buttkus Germany 8 197 0.3× 249 0.4× 187 0.6× 47 0.2× 41 0.3× 17 571

Countries citing papers authored by Mark Cranfield

Since Specialization
Citations

This map shows the geographic impact of Mark Cranfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Cranfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Cranfield more than expected).

Fields of papers citing papers by Mark Cranfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Cranfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Cranfield. The network helps show where Mark Cranfield may publish in the future.

Co-authorship network of co-authors of Mark Cranfield

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Cranfield. A scholar is included among the top collaborators of Mark Cranfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Cranfield. Mark Cranfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wilson, T., et al.. (2019). Oocyte-derived growth factors and ovulation rate in sheep. Bioscientifica Proceedings. 1 indexed citations
2.
Cranfield, Mark, et al.. (2018). Compressed collagen and decellularized tissue – novel components in a pipeline approach for the study of cancer metastasis. BMC Cancer. 18(1). 622–622. 10 indexed citations
3.
Collins‐Hooper, Henry, Graham N. Luke, Mark Cranfield, et al.. (2011). Efficient myogenic reprogramming of adult white fat stem cells and bone marrow stem cells by freshly isolated skeletal muscle fibers. Translational research. 158(6). 334–343. 3 indexed citations
4.
Gold, Elspeth, Xiaowei Zhang, Anthony M. Wheatley, et al.. (2005). βA- and βC-activin, follistatin, activin receptor mRNA and βC-activin peptide expression during rat liver regeneration. Journal of Molecular Endocrinology. 34(2). 505–515. 46 indexed citations
5.
Muttukrishna, Shanthi, et al.. (2005). Development of a sensitive enzyme immunoassay for anti‐Müllerian hormone and the evaluation of potential clinical applications in males and females. Clinical Endocrinology. 63(3). 267–273. 89 indexed citations
6.
Gilchrist, Robert B., Lesley J. Ritter, Mark Cranfield, et al.. (2004). Immunoneutralization of Growth Differentiation Factor 9 Reveals It Partially Accounts for Mouse Oocyte Mitogenic Activity1. Biology of Reproduction. 71(3). 732–739. 77 indexed citations
7.
Gold, Elspeth, Moira K. O’Bryan, Sally L. Mellor, et al.. (2004). Cell-specific expression of βC-activin in the rat reproductive tract, adrenal and liver. Molecular and Cellular Endocrinology. 222(1-2). 61–69. 27 indexed citations
8.
Kaivo-Oja, Noora, Jonas Bondestam, Meerit Kämäräinen, et al.. (2003). Growth Differentiation Factor-9 Induces Smad2 Activation and Inhibin B Production in Cultured Human Granulosa-Luteal Cells. The Journal of Clinical Endocrinology & Metabolism. 88(2). 755–762. 104 indexed citations
9.
Gold, Elspeth, Richard Francis, Arthur Zimmermann, et al.. (2003). Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis. Molecular and Cellular Endocrinology. 201(1-2). 143–153. 26 indexed citations
10.
Mellor, Sally L., Anne E. O’Connor, Jean‐François Éthier, et al.. (2003). Activin βC-Subunit Heterodimers Provide a New Mechanism of Regulating Activin Levels in the Prostate. Endocrinology. 144(10). 4410–4419. 54 indexed citations
11.
McNatty, K. P., Jennifer L. Juengel, T. Wilson, et al.. (2003). Oocyte-derived growth factors and ovulation rate in sheep.. PubMed. 61. 339–51. 58 indexed citations
12.
MacPherson, Sarah E., Karin Williams, Mark Cranfield, et al.. (2002). Development and validation of a new monoclonal antibody to mammalian aromatase. Journal of Endocrinology. 172(1). 21–30. 100 indexed citations
13.
Vejda, Susanne, Mark Cranfield, Barbara Peter, et al.. (2002). Expression and dimerization of the rat activin subunits betaC and betaE: evidence for the ormation of novel activin dimers. Journal of Molecular Endocrinology. 28(2). 137–148. 55 indexed citations
14.
Juengel, Jennifer L., N. L. Hudson, D. A. Heath, et al.. (2002). Growth Differentiation Factor 9 and Bone Morphogenetic Protein 15 Are Essential for Ovarian Follicular Development in Sheep1. Biology of Reproduction. 67(6). 1777–1789. 258 indexed citations
15.
16.
Groome, Nigel P., et al.. (2001). Enzyme immunoassays for inhibins, activins and follistatins. Molecular and Cellular Endocrinology. 180(1-2). 73–77. 23 indexed citations
17.
Mellor, Sally L., Mark Cranfield, John Pedersen, et al.. (2000). Localization of Activin βA-,βB-, andβC-Subunits in Human Prostate and Evidence for Formation of New Activin Heterodimers ofβC-Subunit1. The Journal of Clinical Endocrinology & Metabolism. 85(12). 4851–4858. 92 indexed citations
18.
McNeilly, J. R., Philippa T. K. Saunders, Mary Taggart, et al.. (2000). Loss of Oocytes in Dazl Knockout Mice Results in Maintained Ovarian Steroidogenic Function but Altered Gonadotropin Secretion in Adult Animals. Endocrinology. 141(11). 4284–4294. 45 indexed citations
19.
Roussel, J.D., et al.. (1990). GnRH down-regulation in a superovulation regime for nonhuman primates. Theriogenology. 33(1). 337–337. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Antczak Breakdown of academic impact, for papers by Shoko Yamashita Breakdown of academic impact, for papers by Zheng‐Bin Han Breakdown of academic impact, for papers by L.C. Giudice Breakdown of academic impact, for papers by Ilkka Ketola Breakdown of academic impact, for papers by Noora Kaivo-Oja Breakdown of academic impact, for papers by Lihua Sun Breakdown of academic impact, for papers by Elissavet Hatzi Breakdown of academic impact, for papers by Chencheng Yao Breakdown of academic impact, for papers by Patricia da Silva‐Buttkus
Rankless by CCL
2026